Loading
Life sciences · Preprint
arXiv · September 18, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Preprint.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Multi-label few-shot learning (MLFSL) remains a significant challenge in medical image analysis (MIA). Current metric-based meta-learning methods face two critical limitations in MIA. First, conventional prototype generation often entangles irrelevant disease information, leading to contaminated prototypes and degraded performance. Second, prior studies typically enforce inter-class separability in embedding space, largely neglecting the inherent correlations among diseases. To overcome these challenges, we propose Prototype Purification and Regulation (PPR), a novel MLFSL framework for MIA. PPR first performs prototype purification by leveraging sample-level comorbidity scores to emphasize disease-specific features, producing purified prototypes that better characterize each disease. Building upon these purified prototypes, PPR further addresses the underexplored problem of inter-class prototype distance in MIA by incorporating disease-level comorbidity statistics to adaptively regulate inter-class similarity, forming a comorbidity-aware embedding space. Overall, PPR sequentially enables the model to capture pure disease features and inter-class relationships for reliable MLFSL in MIA. Extensive experiments across four chest X-ray benchmark datasets, including cross-domain evaluation, show that PPR consistently outperforms state-of-the-art methods, significantly improving disease detection while demonstrating robust generalization and clinical applicability.